{"id":"W3094852122","doi":"10.1182/blood-2020-138887","title":"Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Providence Health Care; Leukemia & Lymphoma Society of Canada; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Ibrutinib; Medicine; Chronic lymphocytic leukemia; Discontinuation; Internal medicine; Fludarabine; Oncology; Leukemia; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007217385,0.0001826179,0.0003742456,0.001067027,0.0009429901,0.00146722,0.0007790824,0.0003889077,0.001558401],"category_scores_gemma":[0.00346017,0.000202972,0.0002080877,0.00397855,0.0004660269,0.0003267889,0.0006653338,0.00054876,0.0003078863],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00998966,"about_ca_system_score_gemma":0.007149938,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7535131,"about_ca_topic_score_gemma":0.8208134,"domain_scores_codex":[0.9988537,0.0001763003,0.0001653267,0.0002242124,0.0003154721,0.0002650974],"domain_scores_gemma":[0.9957132,0.0005324506,0.001785019,0.0001605503,0.001071402,0.0007373978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002073964,0.00003305937,0.9924925,0.00006229627,0.00002760239,0.0001884041,0.0004188595,0.0001567906,0.0001947304,0.00003696554,0.001044204,0.005137241],"study_design_scores_gemma":[0.00001411089,0.0000468309,0.9966888,0.0000382906,0.0000175022,0.0002717333,0.0007816994,0.0003055993,0.00006286078,0.00001833499,0.001746105,0.000008244525],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893383,0.0006737727,0.00009703339,0.0002618922,0.000005245261,0.00007630299,0.007571786,0.00001297816,0.001962731],"genre_scores_gemma":[0.9956282,0.000340542,0.0001787764,0.0001728997,0.000006546937,0.00005137807,0.003285581,0.000005214942,0.0003307509],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2464869,"threshold_uncertainty_score":0.495877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02062648055128682,"score_gpt":0.253403528309048,"score_spread":0.2327770477577612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}